MapLight Therapeutics (MPLT) Cash from Investing Activities (2024 - 2025)
MapLight Therapeutics recorded quarterly Cash from Investing Activities of -$242.6 million in Q4 2025, down 848.76% quarter-over-quarter from $32.4 million in Q4 2024, and down 848.76% year-over-year from $32.4 million in Q4 2024.
MapLight Therapeutics' Cash from Investing Activities history runs 2 years deep, the most recent figure standing at -$242.6 million for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | MapLight Therapeutics | 254.43 Mn | 254.43 Mn | - | -242.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -242.55 Mn |
| Dec 31, 2025 | -242.55 Mn |
| Dec 31, 2024 | 32.39 Mn |
| Dec 31, 2024 | 32.39 Mn |